Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Completed · Phase 2 · Has a placebo group

Conditions studied: Platysmal Bands

In brief

Interventional phase 2 study to evaluate safety and efficacy of abobotulinumtoxinA for the treatment of platysmal bands.

Key facts

Study ID

NCT04080882

Run by

Galderma R&D

People needed

80

Starts

2019-09-25

Expected to finish

2020-06-04

Last updated by the study team

2022-08-26

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Moderate to severe platysmal bands at maximum contraction as assessed by the Investigator using a photographic scale
• Platysmal bands graded as Level 3 or 4 at maximum contraction as assessed by the subject using a photographic scale

You may not qualify if…

• Botulinum toxin treatment of any serotype below the lower orbital rim, in the neck or chest within 12 months prior to study treatment

Where it is running

• Galderma Research Site — Encinitas, California, United States
• Galderma Research Site — Encino, California, United States
• Galderma Research Site — Boynton Beach, Florida, United States
• Galderma Research Site — Miami, Florida, United States
• Galderma Research Site — New Orleans, Louisiana, United States
• Galderma Research Site — New Orleans, Louisiana, United States
• Galderma Research Site — Baltimore, Maryland, United States
• Galderma Research Site — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.